Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2021-02-24

Clinical Trial Update: Low Plasma Mannose Binding Lectin (p-MBL) Level is a Risk Factor for Recurrent Pregnancy Loss (RPL)

View source ↗

Summary

Clinical trial completed examining low plasma mannose-binding lectin levels as a risk factor for recurrent pregnancy loss.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Aalborg University Hospital | Conditions: Recurrent Miscarriage, Spontaneous Abortion | Status: COMPLETED | Results posted: 2021-02-24